SMSNA
US$ 23.92
glp 1 receptor agonists effects on cardiovascular risk reduction Frontiers GI Adverse Effects of Glucagon-Like
Description
doi: 10.1016/s0167-0115(96)00113-9
Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, et al
Clinical evidence shows significant improvements in Type 2 diabetes, sleep apnea, and heart health, along with renewed energy, mobility, and emotional balanceproving that surgery changes how the body functions, not just how it looks
Significantly, it has been demonstrated that GLP-1 analogues can suppress NF-B, which is a major activator of IL-6 expression [121]
Figure 12: Photograph Professor Vincent Marks (1930-2023), credit: Seaton)
